Chaotropic Chromatography Method for Simultaneous Determination of Lamivudine, Abacavir and Dolutegravir in Pharmaceutical Formulations-Reference-Cited by-同舟云学术

Chaotropic Chromatography Method for Simultaneous Determination of Lamivudine, Abacavir and Dolutegravir in Pharmaceutical Formulations

Published:2024-02-19 Issue:5 Volume:7 Page:2625-2634
ISSN:2522-5758
Container-title:Chemistry Africa
language:en
Short-container-title:Chemistry Africa

Author:

Labidi Aymen,Jebali Sami,Oueslati Hanen,Sghaier Rafika Ben,Latrous Latifa^ORCID,Megriche Adel

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s42250-024-00911-8.pdf

Reference32 articles.

1. ‘2022-global-aids-update_en.pdf’. Accessed: May 24, 2023. [Online]. Available: https://www.unaids.org/sites/default/files/media_asset/2022-global-aids-update_en.pdf

2. Rodriguez-Gonzalez CG, Chamorro-de-Vega E, Ortega-Navarro C, Alonso R, Herranz-Alonso A, Sanjurjo-Saez M (2020) Effectiveness, safety, and costs of dolutegravir/abacavir/lamivudine single-tablet regimen in a real-life cohort of HIV-1 adult infected patients. Ann Pharmacother 54(7):633–643

3. Christensen BL, Tan DH (2022) An up-to-date evaluation of dolutegravir/abacavir/lamivudine for the treatment of HIV. Expert Opin Pharmacother 23(4):439–446

4. Hocqueloux L et al (2019) ‘Dolutegravir monotherapy versus dolutegravir/abacavir/lamivudine for virologically suppressed people living with chronic human immunodeficiency virus infection: the randomized noninferiority MONotherapy of TiviCAY trial’, Clinical Infectious Diseases, vol. 69, no. 9, pp. 1498–1505

5. Enoki Y et al (Apr. 2021) Multivalent cation and polycation polymer preparations influence pharmacokinetics of dolutegravir via chelation-type drug interactions. Drug Metab Pharmacokinet 37:100371. https://doi.org/10.1016/j.dmpk.2020.11.006